Afficher la notice abrégée

dc.contributor.editorCavallaro, Ugo
dc.contributor.editorGiordano, Marco
dc.date.accessioned2021-05-01T15:46:49Z
dc.date.available2021-05-01T15:46:49Z
dc.date.issued2020
dc.identifierONIX_20210501_9783039434060_1074
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/69328
dc.description.abstractThe cancer stem cell (CSC) paradigm represents one of the most prominent breakthroughs of the last decades in tumor biology. CSCs are that subpopulation within a tumor that can survive conventional therapies and as a consequence are able to fuel tumor recurrence. Nevertheless, the biological characteristics of CSCs and even their existence, remain the main topic among tumor biologists debates. The difficulty in achieving a better definition of CSC biology may actually be explained by the plasticity of such a cell subpopulation. Indeed, the emerging view is that CSCs represent a dynamic “state” of tumor cells that can acquire stemness-related properties under specific circumstances, rather than referring to a well-defined group of cells. Regardless of their origin, it is clear that designing novel antitumor treatments based on the eradication of CSCs will only be possible upon unraveling the biological mechanisms that underlie their pathogenic role in tumor progression and therapy resistance. The Special Issue on “New aspects of cancer stem cell biology: implications for innovative therapies” aims at highlighting recent insights into CSC features that can make them an attractive target for novel therapeutic strategies.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: generalen_US
dc.subject.classificationthema EDItEUR::P Mathematics and Science::PS Biology, life sciencesen_US
dc.subject.otherCadherin 11
dc.subject.otherWNT signaling
dc.subject.otherβ-catenin
dc.subject.othercancer stem cells
dc.subject.otherTNBC
dc.subject.otherearly breast cancer
dc.subject.otherbevacizumab
dc.subject.otherneoadjuvant chemotherapy
dc.subject.otherALDH1
dc.subject.othersolid cancer
dc.subject.otherchemo-resistance
dc.subject.otherHDAC inhibitors
dc.subject.otherhead and neck squamous cell carcinoma
dc.subject.otherSRC
dc.subject.otherdasatinib
dc.subject.othersaracatinib
dc.subject.otherEC-8042
dc.subject.otherOvarian cancer
dc.subject.otherWnt signaling
dc.subject.othertumor progression
dc.subject.othertherapy resistance
dc.subject.otherexosomes
dc.subject.otheroral cancer risk
dc.subject.otheroral epithelial dysplasia
dc.subject.otherSOX2
dc.subject.otherimmunohistochemistry
dc.subject.otheroral squamous cell carcinoma
dc.subject.othergenome-wide
dc.subject.othertranscriptome
dc.subject.otherlung cancer
dc.subject.otherATAC-seq
dc.subject.otherRNA-seq
dc.subject.otherCSCs
dc.subject.otherNSCLC
dc.subject.otherB4GALT1
dc.subject.otherLUAD
dc.subject.otherbreast cancer
dc.subject.otherlipid
dc.subject.othermetabolism
dc.subject.othertherapeutic resistance
dc.subject.otherbowel cancer
dc.subject.otherorganoid
dc.subject.othertumoroid
dc.subject.othercolorectal
dc.subject.othercolon
dc.subject.otherstem cell
dc.subject.otherchemotherapy resistance
dc.subject.otherovarian cancer
dc.subject.othercancer stem cell
dc.subject.othergenetic heterogeneity
dc.subject.otherSNP array
dc.subject.otherL1CAM
dc.subject.otherchemoresistance
dc.subject.otherepithelial-mesenchymal transition
dc.subject.othercancer therapy
dc.subject.othercell adhesion molecule
dc.titleNew Aspects of Cancer Stem Cell Biology
dc.title.alternativeImplications for Innovative Therapies
dc.typebook
oapen.identifier.doi10.3390/books978-3-03943-407-7
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0
oapen.relation.isbn9783039434060
oapen.relation.isbn9783039434077
oapen.pages208
oapen.place.publicationBasel, Switzerland


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

https://creativecommons.org/licenses/by/4.0/
Excepté là où spécifié autrement, la license de ce document est décrite en tant que https://creativecommons.org/licenses/by/4.0/